Blood Cancer Diagnostics Market

Worldwide Cancer Diagnostics Is Anticipated To Rise At A Healthy CAGR Of 6% Over 2021–2031| Fact.MR study

Key Takeaways

– Global market for blood cancer diagnostics to rise at a healthy CAGR of nearly 6% through 2031. – Increasing healthcare expenditure, rising prevalence of cancer, technological advancements, and affordable diagnostic equipment and devices are some of the major factors guiding industry evolution. – North America is expected to hold around 40% of the global market share in terms of revenue.

Key players

– Abbott Laboratories – Roche Holding A.G. – Thermo Fisher Scientific Inc. – Laboratory Corporation of America Holdings – Luminex Corporation – Myriad Genetics Inc.

“Adoption of unhealthy and improper lifestyle has increased the occurrence of various types of diseases such as cancer, which, in turn, has driven demand for better and more efficient diagnostic solutions,” says a Fact.MR analyst.

Analyst View

Explore Fact.MR’s Domain Coverage On Healthcare